Novo Nordisk clinical-trial and HCP data leak
Data Leak
Summary
Hide ▲
Show ▼
Novo Nordisk disclosed externally copied non-public data affecting clinical-trial participants and some healthcare professionals, raising exposure risk for sensitive records and contact details. The exposed material includes patient IDs, trial participation details, biomarkers, health/immunogenicity data, lifestyle factors, and HCP names, phone numbers, and office locations. The company said the patient records were pseudonymized, but the HCP details could support phishing and impersonation attempts. Novo Nordisk took the compromised internal IT systems offline while investigators assess the full scope of the leak.
Timeline
-
12.06.2026 13:13 2 articles · 7h ago
Novo Nordisk discloses breach of clinical-trial and healthcare professional data
Initial DisclosureNovo Nordisk disclosed that attackers gained access to its internal IT systems and copied non-public data tied to some clinical trials and an undisclosed number of healthcare professionals. The exposed material includes pseudonymized patient IDs, trial participation details, sex, year of birth, biomarkers, health and immunogenicity data, lifestyle factors, and HCP names, registration numbers, e-mail addresses, phone numbers, WhatsApp details, and office locations. The company said the patient data was not directly linked to names, warned affected HCPs about phishing and impersonation attempts, took the compromised internal IT systems offline, and said core business operations were not impacted while external cybersecurity experts help assess the breach.
Show sources
- Pharma giant Novo Nordisk discloses breach of clinical trials data — www.bleepingcomputer.com — 12.06.2026 13:13
- Pharma giant Novo Nordisk discloses breach of clinical trials data — www.bleepingcomputer.com — 12.06.2026 13:13